The eight Chinese companies who could be blacklisted by the Drug Controller General of India (DCGI) are
As these companies are supplying a big part of the overall raw material imported to India, imposing restrictions against them could result in a shortage of medicines in India. 70 % of the overall raw material comes from China, mostly due to the fact that it is four times cheaper than those produced in India. The Indian government has meanwhile also decided to inspect APIs imported from other countries such as the United States, Italy and other European nations.
> Zögern Sie nicht, wir freuen uns auf Ihr Feedback!
Schreiben Sie einen Kommentar zu dieser Meldung.